LENZ Therapeutics, Inc. (LENZ)
Across 16 earnings reports since Aug 12, 2021, LENZ Therapeutics, Inc. (LENZ) has a clear post-earnings pattern. It moves ±7.90% on average after reporting and finishes higher 37.5% of the time. Its largest post-earnings gain was +12.5% (Nov 06, 2024) and its largest decline was -23.46% (Nov 05, 2025). The next earnings report is predicted for 2026-08-14 (estimated).
Earnings reactions
How LENZ moved on each past earnings report.
Earnings Impact
Total Earnings
16
Avg Abs. Movement
±7.90%
Positive %
37.5%
Negative %
62.5%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 11, 2026 | ☽ POST | -20.94% | open_in_new |
| Mar 24, 2026 | ☀ PRE | -17.91% | open_in_new |
| Nov 05, 2025 | ☀ PRE | -23.46% | open_in_new |
| Jul 30, 2025 | ☀ PRE | -2.87% | open_in_new |
Earnings Count
16
Total earnings in dataset
Avg Abs. Movement
±7.90%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260702 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260626 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
Frequently asked about LENZ earnings
When does LENZ Therapeutics, Inc. report earnings next? expand_more
LENZ Therapeutics, Inc. (LENZ)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LENZ stock move after earnings? expand_more
Over 16 reports, LENZ has moved an average of ±7.90% the session after earnings, closing higher 37.5% of the time.
What was LENZ's biggest post-earnings move? expand_more
LENZ's largest post-earnings gain on record was +12.5% on Nov 06, 2024, and its largest decline was -23.46% on Nov 05, 2025.
Where can I find LENZ Therapeutics, Inc.'s SEC filings? expand_more
All of LENZ Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right